- Home
- STG vs IMA Comparison
STG vs IMA Comparison
Compare STG & IMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STG
- IMA
- Stock Information
- Founded
- STG 2003
- IMA 2019
- Country
- STG China
- IMA United States
- Employees
- STG N/A
- IMA N/A
- Industry
- STG Other Consumer Services
- IMA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- STG Real Estate
- IMA Health Care
- Exchange
- STG Nasdaq
- IMA Nasdaq
- Market Cap
- STG 112.4M
- IMA 92.2M
- IPO Year
- STG 2018
- IMA N/A
- Fundamental
- Price
- STG $5.66
- IMA $8.22
- Analyst Decision
- STG
- IMA Buy
- Analyst Count
- STG 0
- IMA 1
- Target Price
- STG N/A
- IMA $30.00
- AVG Volume (30 Days)
- STG 2.6K
- IMA 66.9K
- Earning Date
- STG 11-20-2025
- IMA 11-13-2025
- Dividend Yield
- STG N/A
- IMA N/A
- EPS Growth
- STG N/A
- IMA N/A
- EPS
- STG 3.59
- IMA N/A
- Revenue
- STG $279,374,215.00
- IMA $4,300,000.00
- Revenue This Year
- STG N/A
- IMA N/A
- Revenue Next Year
- STG N/A
- IMA N/A
- P/E Ratio
- STG $1.57
- IMA N/A
- Revenue Growth
- STG N/A
- IMA N/A
- 52 Week Low
- STG $4.28
- IMA $7.24
- 52 Week High
- STG $15.00
- IMA $23.28
- Technical
- Relative Strength Index (RSI)
- STG 25.52
- IMA N/A
- Support Level
- STG $6.20
- IMA N/A
- Resistance Level
- STG $6.98
- IMA N/A
- Average True Range (ATR)
- STG 0.17
- IMA 0.00
- MACD
- STG -0.07
- IMA 0.00
- Stochastic Oscillator
- STG 13.07
- IMA 0.00
About STG Sunlands Technology Group
Sunlands Technology Group is a provider of online post-secondary and professional education services in China. The company offers various degree- and diploma-oriented post-secondary courses through its online platforms. In addition, it provides online professional courses and educational content to help students prepare for professional certification exams and attain professional skills. The Group has one operating segment, which is the provision of online education services.
About IMA ImageneBio Inc. Common Stock
ImageneBio Inc is a clinical-stage biopharmaceutical company that develops differentiated therapies for immunological and inflammatory (I&I) diseases. The company is focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody, for the treatment of atopic dermatitis.